Navigation Links
Spending on Diabetes Drugs Soars in US

One more indicator of the growing epidemic of diabetes in the US is out. Spending on diabetes drugs is spiraling by leaps and bounds .

According to a drug trend report released by the Medico Health Solutions, diabetes treatments trailed only cholesterol medications in total prescription drug spending growth in 2006.

An aging population and the alarming rise in obesity a leading cause of diabetes are expected to push spending growth rates on diabetes drugs up 16 percent to 20 percent annually.

The analysis projects that, by 2009, spending on medicines to treat diabetes could soar by 60 percent to 68 percent from 2006 levels. Spending on diabetes treatments increased 14.5 percent from 2005 to 2006 and the use of diabetes drugs increased 5.1 percent. The U.S. sales of diabetes drugs reached $9.88 billion in 2005.

Use is expected to increase by 8 percent to 10 percent each year, with patients more frequently using new drug combinations to reach target blood sugar levels, the Medco analysis of likely future prescription drug spending and utilization found.

There are going to be a lot more drugs coming out and more and more people with type 2 diabetes will catapult diabetes to the number one class in driving year over year spending growth, Dr. Lon Castle, director of medical policy for Medco, said in an interview.

A wave of new diabetes treatments, such as Merck & Co.s, Januvia, and Byetta from Eli Lilly and Co. and Amylin Pharmaceuticals Inc.; and others expected to hit the market from the likes of Novartis AG and Novo Nordisk A/S will help push up treatment costs, the report said.

Some newer drugs that act on new targets are increasingly being prescribed as first-line therapy and are frequently being used in combination with other drugs, driving up costs this year and going forward, the report said.

Use of lower cost generic drugs could mitigate pricing pressures, said Medco, a pharmacy benefits manager that negotiates prescription drug costs for companies and other large clients.

But while new medicines and combination therapies can be expensive, the cost of treating complications from untreated diabetes would create a much larger burden on government and private health plans and patient pocketbooks.

Diabetes and, in particular, type 2 diabetes, is becoming much more prevalent among people of all ages, Medco Chief Medical Officer Robert Epstein said in a statement.

While prevention of type 2 diabetes needs to be a national priority, drug treatments can help prevent the onset of complications from diabetes that lead to hospitalizations, more complex treatment and dramatically higher costs, Epstein said.


'"/>




Related medicine news :

1. More Spending Does Not Ensure Better Healthcare
2. Western Australian Government Spending Extra For Mental Health Services
3. Lowest Spending growth in US Medicaid
4. Variation in U.S. Healthcare Spending
5. States Spending may Help Keep Childless Seniors Independent
6. Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending
7. G8 Members To Announce Plans To Increase HIV/AIDS Spending at Summit
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. Diabetes and Depression often go hand-in-hand
10. Thirty minutes of work up per day reduces the risk of Diabetes
11. Diabetes on the rise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2016)... ... ... May 26, 2016- In search of the K. Warriors, Shaolin Institute is ... Warriors” on June 4, 2016 at Ashbury Hotel and Suites 600 West Interstate 65 ... by Shaolin Institute and sanctioned by KSF (Kungfu Sanda Federation), This is the 28th ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon ... to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel ... year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program at ...
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... in scholarships to students studying complementary medicine. Allison Outerbridge is this year’s ... her award on May 18 at the university’s Student Leadership Awards ceremony. , ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... thousands of defective respirators, according to court documents and SEC filings. A ... and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/26/2016)... A key trend that will ... of new treatments. Cardax, a development stage life sciences ... therapy is expected to fulfil large unmet medical needs ... studies to develop new treatments for osteoarthritis. One such ... in osteoarthritis are being investigated, and early trials of ...
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
Breaking Medicine Technology: